Advances in cancer treatment using immunotherapies has accelerated the need to examine the tumor immune microenvironment (TIME). Multiplex immunofluorescence (mIF) assays allow the researcher to ...

Pharmacokinetics (PK) of CR011-vcMMAE, an antibody-drug conjugate (ADC), in a phase (Ph) I study of patients (pts) with advanced melanoma This is an ASCO Meeting Abstract from the 2009 ASCO Annual ...

Personalized medicine depends on tools, such as immunohistochemistry (IHC), that identify precise targets in a patient’s disease. Immunohistochemistry (IHC) staining is integral in developing ...

LAUSANNE, Switzerland & DANVERS, Mass.--(BUSINESS WIRE)--Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Cell Signaling Technology ...

Three dimensional immunohistochemistry (3D-IHC) has transformed our ability to visualize the spatial arrangement of cells and molecules in intact tissues. However, traditional methods are often ...